Collectively, these data, combined with our previous observations that elevated NNAT correlated with better survival of ER + breast cancer patients [9], suggest that NNAT is a key regulator of Ca2+ homeostasis that impacts ER + breast cancer cell progression. The gene discussed is NNAT; the disease is breast carcinoma.